Injectables Formulation Facility – Vials and Ampoules
Built up Area = 7,537 sq.m
Facility for Gonadotropins including Protein purification.
Produces both Liquid and Lyophilized Injectables in Vials and Ampoules.
Entire development comprises of Production block, Bio Lab (Animal House), Protein Purification section and ancillary areas like utility block, ETP area, Security cabin, fuel yard and Pump house.
The project is approved by UK MHRA & ANVISA.
Morison PLC - Colombo, Sri Lanka
Oral Solids & Liquids Dosage Formulation Facility
Built up Area = 16,728 sq.m
Greenfield project built on a 5-acre plot for Tablets, Capsules, Liquids (Multi-level manufacturing)
Annual production capacity of 5 billion tablets and 10 million bottles.
The plant is designed for minimum human intervention to prevent human error and includes cutting edge equipment such as the fully automated liquid manufacturing and packing lines, fully-fledged chemical and microbiology labs, separate air handling units to control environment conditions.
The plant is being set up in a plot of about 36,000 Sq.m with an overall built-up area of proposed facility of about 10,000 Sq.m. The facility will produce Pharmaceutical products under general category. The dosage forms and their annual production volumes include Tablets (180 Million), Capsules (45 Million), Liquid Syrups (6 Million) and Ointments/ Creams (3 Million) .
Main block will house of Change Rooms, Production Area, Warehouse, Formulation Development Section, Quality Assurance, Quality Control, Administration Departments, Laundry and Technical area.
Pharmax Pharmaceuticals - Dubai, UAE
Oral Solids Dosage Formulation Facility
Built up Area = 8,828 Sq.m
The Facility is designed for manufacturing Oral Solid Dosage formulations under General category with plans to expand and set up facilities for the other pharmaceutical dosages in near future, in the industrial area at Dubai Science Park, Dubai
The facility produces 195 million tablets per year & 10 million Capsules (Hard Gelatin) per year.
The core areas are planned in Modular Panels. The Cooling system is designed considering the Distinct Cooling system.
The facility is designed in compliance with requirements of the various local authorities like DEWA, DM, and DCDA, etc. and designed to meet cGMP requirements of regulatory bodies like US FDA, EU and GCC.